DK1231213T3 - Fremgangsmåde til fremstilling af rene phosphatider og anvendelse deraf i kosmetika, på det farmaceutiske område og til næringsmidler - Google Patents

Fremgangsmåde til fremstilling af rene phosphatider og anvendelse deraf i kosmetika, på det farmaceutiske område og til næringsmidler

Info

Publication number
DK1231213T3
DK1231213T3 DK02002360T DK02002360T DK1231213T3 DK 1231213 T3 DK1231213 T3 DK 1231213T3 DK 02002360 T DK02002360 T DK 02002360T DK 02002360 T DK02002360 T DK 02002360T DK 1231213 T3 DK1231213 T3 DK 1231213T3
Authority
DK
Denmark
Prior art keywords
phosphatides
preparation
foodstuffs
cosmetics
pharmaceutical field
Prior art date
Application number
DK02002360T
Other languages
Danish (da)
English (en)
Inventor
Guenter Kirschner
Giampaolo Menon
Susanna Vaccaro
Original Assignee
Fidia Farmaceutici
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11452205&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1231213(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fidia Farmaceutici filed Critical Fidia Farmaceutici
Application granted granted Critical
Publication of DK1231213T3 publication Critical patent/DK1231213T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids
    • C12P13/06—Alanine; Leucine; Isoleucine; Serine; Homoserine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P9/00—Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Birds (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
DK02002360T 2001-02-09 2002-01-31 Fremgangsmåde til fremstilling af rene phosphatider og anvendelse deraf i kosmetika, på det farmaceutiske område og til næringsmidler DK1231213T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001PD000031A ITPD20010031A1 (it) 2001-02-09 2001-02-09 Procedimento per la preparazione di fosfatidi puri e loro impiego in campo cosmetico, farmaceutico ed alimentare.

Publications (1)

Publication Number Publication Date
DK1231213T3 true DK1231213T3 (da) 2004-12-06

Family

ID=11452205

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02002360T DK1231213T3 (da) 2001-02-09 2002-01-31 Fremgangsmåde til fremstilling af rene phosphatider og anvendelse deraf i kosmetika, på det farmaceutiske område og til næringsmidler

Country Status (16)

Country Link
EP (1) EP1231213B1 (fr)
JP (2) JP2002253288A (fr)
AT (1) ATE273313T1 (fr)
AU (1) AU766891B2 (fr)
CA (1) CA2366705C (fr)
CZ (1) CZ20032137A3 (fr)
DE (1) DE60200895T2 (fr)
DK (1) DK1231213T3 (fr)
ES (1) ES2225662T3 (fr)
HK (1) HK1049166B (fr)
HU (1) HUP0303977A3 (fr)
IT (1) ITPD20010031A1 (fr)
NO (1) NO317429B1 (fr)
PL (1) PL362845A1 (fr)
RU (1) RU2289625C2 (fr)
WO (1) WO2002064603A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10142014B4 (de) 2001-08-28 2004-11-11 Degussa Bioactives Deutschland Gmbh & Co. Kg Verfahren zur Herstellung von Phosphatidylserin
IL150240A (en) * 2002-06-16 2005-07-25 Lipogen Ltd Infant formula supplemented with phospholipids
DE102004002053A1 (de) * 2004-01-15 2005-08-04 Bioghurt Biogarde Gmbh & Co. Kg Verfahren zur Herstellung von Phosphatidylserin und dessen Reinigung durch Extraktion
US20050158835A1 (en) * 2004-01-21 2005-07-21 Su Chen Preparation of highly polyunsaturated fatty acid-containing phosphatidylserine and phosphatidic acid
JP2005318827A (ja) * 2004-05-07 2005-11-17 Nisshin Oillio Group Ltd セリンの回収方法
KR20060066624A (ko) * 2004-10-20 2006-06-16 주식회사 두산 포스파티딜세린을 함유하는 피부 보호 및 개선용 또는 피부장벽 기능 강화용 조성물
ITPD20050164A1 (it) 2005-05-30 2006-11-30 Fidia Farmaceutici Processo per la preparazione e l'isolamento di fosfatidi
US20080187511A1 (en) * 2006-10-25 2008-08-07 University Of Pittsburgh-Of The Commonwealth Ointment for cancer treatment
RU2482186C2 (ru) * 2008-05-15 2013-05-20 Лодерс Кроклан Б.В. Способ получения фосфатидилсерина
US8546104B2 (en) 2008-08-07 2013-10-01 Lipogen Ltd. Processes for the preparation of phosphatide salts
JP5432563B2 (ja) * 2009-03-31 2014-03-05 株式会社ファンケル ホスファチジルセリン含有カプセル及びカプセル充填用ホスファチジルセリン組成物
CN103074390A (zh) * 2011-11-02 2013-05-01 江南大学 一种酶法制备不含溶血磷脂和磷脂酸的磷脂酰丙醇的方法
ITPD20120021A1 (it) 2012-01-26 2013-07-27 Fidia Farmaceutici "nuove composizioni farmaceutiche contenenti fosfatidilserina e curcumina".

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6098995A (ja) * 1983-11-04 1985-06-01 Microbial Chem Res Found 光学活性３−（３，４−ジヒドロキシフエニル）セリン，およびその誘導体の製造法
US5700668A (en) * 1995-12-08 1997-12-23 Italfarmaco Sud S.P.A. Process for the industrial preparation of phosphatidylserine
DE19917249C2 (de) * 1999-02-26 2001-09-27 Meyer Lucas Gmbh & Co Verfahren zur Herstellung von Phosphatidylserin-Produkten
IT1311929B1 (it) * 1999-04-28 2002-03-20 Chemi Spa Procedimento per la preparazione di fosfatidilserine.

Also Published As

Publication number Publication date
JP2002253288A (ja) 2002-09-10
HK1049166B (en) 2005-04-22
HK1049166A1 (en) 2003-05-02
EP1231213A1 (fr) 2002-08-14
RU2289625C2 (ru) 2006-12-20
CA2366705C (fr) 2006-09-12
NO317429B1 (no) 2004-10-25
CZ20032137A3 (cs) 2004-02-18
DE60200895D1 (de) 2004-09-16
HUP0303977A3 (en) 2011-01-28
PL362845A1 (en) 2004-11-02
ATE273313T1 (de) 2004-08-15
ES2225662T3 (es) 2005-03-16
AU766891B2 (en) 2003-10-23
EP1231213B1 (fr) 2004-08-11
JP2007259866A (ja) 2007-10-11
NO20020019L (no) 2002-08-12
HUP0303977A2 (hu) 2004-03-29
CA2366705A1 (fr) 2002-08-09
ITPD20010031A1 (it) 2002-08-09
WO2002064603A1 (fr) 2002-08-22
AU1006402A (en) 2002-08-15
NO20020019D0 (no) 2002-01-03
RU2003125183A (ru) 2005-03-20
DE60200895T2 (de) 2005-09-01

Similar Documents

Publication Publication Date Title
NO20020019L (no) Fremgangsmåte til fremstilling av rene fostatider og deres anvendelse på kosmetikk-, farmasöytiske- og ern¶ringsområder
BR0008188A (pt) Inibidores de fator de diferenciação de crescimento e usos para os mesmos
IL160915A0 (en) Indolizines inhibiting kinase proteins
DE60232104D1 (de) Nahrungsergänzung zur Behandlung von Makula Degeneration
BR0211482A (pt) Pirazolilcarboxanilidas como fungicidas
DE60220415D1 (de) Flavonoide und mehrfach ungesättigte fettsäuren enthaltende natürliche phospholipide maritimen ursprungs sowie deren anwendungen
EA200801565A1 (ru) Производные пиримидиниларилмочевины в качестве ингибиторов фактора роста фибробластов ( fgf-фактора )
BRPI0412894A (pt) tienopiridina e furopiridina inibidores de quinases
BR0108713A (pt) Expressão hìbrida de proteìnas de neisseria
BR0208338A (pt) Derivados de piridina
DE69504184D1 (de) Neue kationische phospholipide zur transfektion
ATE392430T1 (de) Verfahren zur herstellung von dipeptiden
DE60332024D1 (de) Verfahren zur herstellung von soja protein
ATE430759T1 (de) Kationische sterolderivate, ph-sensitive liposomen diese umfassend und verfahren zur wirkstoffbeladung von liposomen
CO5050398A1 (es) Acidos eter-carboxilicos como dispensantes de asfaltenos en petroleos y procedimiento para dispensar tales asfaltenos
AR036962A1 (es) Metiltransferasas aromaticas y usos de las mismas
NO962604L (no) Næringsmiddel
BR0317284A (pt) Inibidores aminocianopiridina de proteìna quinase-2 ativada com proteìna quinase ativada com mitógeno
UY27606A1 (es) Inhibidores de la fosfarasa
IL168718A (en) Biguanide derivatives, compositions comprising the derivatives, process for preparing an antimicrobial compound and use of the derivatives in the preparation of medicaments
EA200600833A1 (ru) Тиазолидиноны, их получение и применение как фармацевтических агентов
BRPI0406037A (pt) Produto de carne ou análogo de carne contendo soja, e, método para preparar o mesmo
UY26675A1 (es) Sales de imidazo-3-aminas e imidazo-5-aminas bicíclicas n-aciladas y sus productos de adicción con ácidos, procedimientos para su preparación y medicamentos que contienen estos compuestos
ATE204851T1 (de) Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten
WO2004087652A3 (fr) Composes d'imidazotriazine